Florence, Italy

Maurizio Pandolfi


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1984-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Maurizio Pandolfi

Introduction

Maurizio Pandolfi is an accomplished inventor based in Florence, Italy. He has made significant contributions to the field of medical science, particularly in the development of innovative treatments for thrombus formation and related conditions. With a total of 2 patents, his work has the potential to impact various medical practices.

Latest Patents

Pandolfi's latest patents include a composition containing and method of using a fibrinolytic active. This natural active principle, known as angiokinase, is derived from mammalian connective tissue, such as that from cattle. The active principle serves as a new drug for the prophylaxis and treatment of abnormal fibrin formation and thrombus formation in various sites, including atherosclerotic diseases and diabetic retinopathy, as well as thrombosis and thromboembolisms. Another patent focuses on the process for producing this vasal fibrinolytic active principle, further emphasizing the importance of angiokinase in medical applications.

Career Highlights

Throughout his career, Maurizio Pandolfi has worked with notable companies, including Società Italo-Britannica L. Manetti-H. Roberts & C. His experience in these organizations has contributed to his expertise in the field and has facilitated the development of his innovative patents.

Collaborations

Pandolfi has collaborated with various professionals, including his coworker Gaetano Comi. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented inventions.

Conclusion

Maurizio Pandolfi's contributions to medical science through his innovative patents highlight his dedication to improving health outcomes. His work with angiokinase represents a significant advancement in the treatment of thrombus-related conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…